Health care stocks were flat to lower premarket Thursday with the iShares Biotechnology ETF (IBB) recently inactive and the Health Care Select Sector SPDR Fund (XLV) down 0.5% recently.
UnitedHealth Group (UNH) shares were down nearly 4% after the company reported a lower-than-expected Q4 revenue.
Incyte (INCY) and Syndax Pharmaceuticals (SNDX) said the US Food and Drug Administration has approved Niktimvo as a treatment for certain patients with chronic graft-versus-host disease who weigh at least 40 kg. Syndax Pharmaceuticals shares were 2% higher premarket.
Seres Therapeutics (MCRB) said it received a $50 million installment related to the sale of its VOWST business to Societe des Produits Nestle. Seres Therapeutics shares were down nearly 4% pre-bell.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。